Showing results (131-140 of 361) with videos related to
Sort By:
Pageof 37
Journal of Hepatology|January 1, 1985
Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver diseaseD M Novick, A S Lok, H C ThomasLancet (London, England)|November 21, 1987
Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriersE M McDonald, A H Mann, H C ThomasClinical and Experimental Immunology|October 1, 1976
Double-stranded DNA-binding capacity of serum in acute and chronic liver diseaseS Jain, R Markham, H C Thomas, et al.Journal of Medical Virology|January 1, 1982
Genetic and sex-linked factors influencing HBs antigen clearance. I. Nonimmune clearance in inbred strains of miceA Craxi, L Montáno, A Goodall, et al.Journal of Hepatology|January 1, 1986
Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experienceH C Thomas, L J Scully, J A McDonaldJournal of Viral Hepatitis|March 5, 2003
Cerebral dysfunction in chronic hepatitis C infectionD M Forton, S D Taylor-Robinson, H C ThomasJournal of Hepatology|February 1, 1987
In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5A A Dunk, D Brown, K Weidmann, et al.Gastroenterology|May 1, 1980
Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosisB J Potter, E Elias, H C Thomas, et al.Journal of Hepatology|January 1, 1986
Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinomaA A Dunk, T Ikeda, M Pignatelli, et al.Journal of Medical Virology|January 27, 1998
A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodiesJ A Waters, C Bailey, C Love, et al.Pageof 37